Top compounds associated with response to DNLZ


Feature Type Standardized
Nominal ANOVA
mRNA selumetinib:navitoclax (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.017 0.6
mRNA BRD-K13185470 CTRPv2 pan-cancer AAC -0.033 0.6
mRNA CAY10576 CTRPv2 pan-cancer AAC -0.018 0.6
mRNA ouabain CTRPv2 pan-cancer AAC -0.016 0.6
mRNA parbendazole CTRPv2 pan-cancer AAC 0.014 0.7
mRNA CIL55A CTRPv2 pan-cancer AAC -0.022 0.7
mRNA CBB-1007 CTRPv2 pan-cancer AAC -0.024 0.7
mRNA navitoclax:gemcitabine (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.015 0.7
mRNA Crizotinib CTRPv2 pan-cancer AAC -0.014 0.7
mRNA etomoxir CTRPv2 pan-cancer AAC -0.016 0.7
Download CSV